Clinical Trials for Kodiak Sciences

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Kodiak Sciences

Clinical Trials (4)

NCT06990399
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK
PHASE3Recruiting
150 participants
Started: Jul 30, 2025 · Completed: Jul 31, 2027
1 condition1 sponsor33 locations
NCT06996080
A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE
PHASE3Recruiting
150 participants
Started: Jul 16, 2025 · Completed: Jul 31, 2027
1 condition1 sponsor33 locations
NCT06556368
A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK
PHASE3Recruiting
675 participants
Started: Aug 23, 2024 · Completed: Apr 30, 2027
1 condition1 sponsor78 locations
NCT06270836
A Study to Evaluate the Efficacy and Safety of Tarcocimab Tedromer Compared With Sham Treatment in Participants With Diabetic Retinopathy (DR)
PHASE3Active, not recruiting
255 participants
Started: May 1, 2024 · Completed: Jan 31, 2026
1 condition1 sponsor38 locations